Centro de Investigación en Medicina Molecular e Enfermidades Crónicas (CIMUS)
Centro singular
Universidad Nacional Autónoma de México
Ciudad de México, MéxicoPublicacións en colaboración con investigadores/as de Universidad Nacional Autónoma de México (8)
2024
2022
-
Endogenous Levels of Alpha-Synuclein Modulate Seeding and Aggregation in Cultured Cells
Molecular Neurobiology, Vol. 59, Núm. 2, pp. 1273-1284
2019
-
Clinical Impact of the Polypill for Cardiovascular Prevention in Latin America: A Consensus Statement of the Inter-American Society of Cardiology
Global Heart, Vol. 14, Núm. 1, pp. 3-16.e1
2018
-
RNA-dependent chromatin targeting of TET2 for endogenous retrovirus control in pluripotent stem cells
Nature Genetics, Vol. 50, Núm. 3, pp. 443-451
2012
-
Reconstructing Native American population history
Nature, Vol. 488, Núm. 7411, pp. 370-374
2005
-
Hydralazine decreases sodium nitroprusside-induced rat aortic ring relaxation and increased cGMP production by rat aortic myocytes
Life Sciences, Vol. 77, Núm. 24, pp. 3105-3116
2003
-
Effects of hydrazine derivatives on vascular smooth muscle contractility, blood pressure and cGMP production in rats: Comparison with hydralazine
Vascular Pharmacology, Vol. 40, Núm. 1, pp. 13-21